The correlation between atherogenic indexes and erectile dysfunction

References

• Consensus Development Conference Statement. National Institutes of Health. Impotence. December 7–9, 1992. Int J Impot Res. 1993;5(4):181–284.
   PubMedGoogle Scholar
• Miner M, Kim ED. Cardiovascular disease and male sexual dysfunction. Asian J Androl. 2015;17(1):3–4.
   PubMed Web of Science ®Google Scholar
• Erenpreiss J, Fodina V, Pozarska R, et al. Prevalence of testosterone deficiency among aging men with and without morbidities. Aging Male. 2019;1:1–5.
   Web of Science ®Google Scholar
• Jensen J, Lendorf A, Stimpel H, et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens. 1999;12(3):271–275.
   PubMed Web of Science ®Google Scholar
• Altunkol A, Topuz AN, Genc O, et al. Atrial electromechanical duration prolongs in patients with erectile dysfunction. Aging Male. 2019;7:1–7.
   Web of Science ®Google Scholar
• Condorelli RA, Calogero AE, Vicari E, et al. Endothelial progenitor cells and erectile dysfunction: a brief review on diagnostic significance and summary of our experience. Aging Male. 2013;16(2):29–32.
   PubMed Web of Science ®Google Scholar
• Kwon H, Lee DG, Kang HC, et al. The relationship between testosterone, metabolic syndrome, and mean carotid intima-media thickness in aging men. Aging Male. 2014;17(4):211–215.
   PubMed Web of Science ®Google Scholar
• Kawada T, Otsuka T, Endo T, et al. Aging, components of metabolic syndrome and serum C-reactive protein showed significant relationship with carotid atherosclerosis. Aging Male. 2012;15(1):42–47.
   PubMed Web of Science ®Google Scholar
• Azadzoi KM, Siroky MB, Goldstein I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol. 1996;155(5):1795–1800.
   PubMed Web of Science ®Google Scholar
• Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J. 2006;27(22):2632–2639.
   PubMed Web of Science ®Google Scholar
• Velioglu Y, Yuksel A. Complete blood count parameters in peripheral arterial disease. Aging Male. 2019;22(3):187–191.
   PubMed Web of Science ®Google Scholar
• Rezanezhad B, Borgquist R, Willenheimer R, et al. Association between serum levels of testosterone and biomarkers of subclinical atherosclerosis. Aging Male. 2018;21(3):182–186.
   PubMed Web of Science ®Google Scholar
• Yu XH, Zhao J, Zhang SC, et al. The impact of age, BMI and sex hormone on aging males’ symptoms and the international index of erectile function scores. Aging Male. 2017;20(4):235–240.
   PubMed Web of Science ®Google Scholar
• Edwards MK, Blaha MJ, Loprinzi PD. Atherogenic index of plasma and triglyceride/high-density lipoprotein cholesterol ratio predict mortality risk better than individual cholesterol risk factors, among an older adult population. Mayo Clin Proc. 2017;92(4):680–681.
   PubMed Web of Science ®Google Scholar
• Öztürk Mİ, Koca O, Keleş MO, et al. Question for a questionnaire: the International Index of Erectile Function. Int J Impot Res. 2011;23(1):24–26.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–830.
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54(2):346–351.
   PubMed Web of Science ®Google Scholar
• Bortolotti A, Parazzini F, Colli E, et al. The epidemiology of erectile dysfunction and its risk factors. Int J Androl. 1998;20(6):323–334.
   Google Scholar
• Zhan Y, Xu T, Tan X. Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: atherogenic index of plasma, neutrophil–lymphocyte ratio. BMC Cardiovasc Disord. 2016;16(1):96.
   PubMed Web of Science ®Google Scholar
• Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol. 2006;50(4):721–731.
   PubMed Web of Science ®Google Scholar
• Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64(7):848–857.
   PubMed Web of Science ®Google Scholar
• Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004;171(6 Part 1):2341–2345.
   PubMed Web of Science ®Google Scholar
• Aldemir M, Okulu E, Neşelioğlu S, et al. Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction. Andrologia. 2012;44 (Suppl. 1):266–271.
   PubMed Web of Science ®Google Scholar
• Otunctemur A, Sahin S, Ozbek E, et al. Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease. Andrologia. 2015;47(6):706–710.
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2019;16:1–5.
   Web of Science ®Google Scholar
• Sood R, Sharma D, Goel H, et al. The correlation between erectile dysfunction and metabolic syndrome in an Indian population: a cross-sectional observational study. Arab J Urol. 2019;17(3):221–227.
   PubMed Web of Science ®Google Scholar
• Sanjay S, Bharti GS, Manish G, et al. Metabolic syndrome: an independent risk factor for erectile dysfunction. Indian J Endocr Metab. 2015;19(2):277–282.
   PubMedGoogle Scholar
• Kalelioglu T, Genc A, Karamustafalioglu N, et al. Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment. Diabetes Metabol Syndr. 2017;11(Suppl. 1):S473–S475.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Risk stratification of dyslipidemia: insights from the Framingham Study. Curr Med Chem Cardiovasc Hematol Agents. 2005;3(3):187–193.
   PubMedGoogle Scholar
• Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85(1):37–45.
   PubMed Web of Science ®Google Scholar
• Vargas HO, Nunes SO, Barbosa DS, et al. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 2014;102(1):65–71.
   PubMed Web of Science ®Google Scholar
• Nwagha UI, Ikekpeazu EJ, Ejezie FE, et al. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010;10(3):248–252.
   PubMed Web of Science ®Google Scholar
• Dobiasova M. AIP—atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52(1):64–71.
   PubMedGoogle Scholar
• Uslu AU, Kucuk A, Icli A, et al. Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus. Eurasian J Med. 2017;49(3):193–197.
   PubMed Web of Science ®Google Scholar
• Ermis E, Ozbay Ozyilmaz S, Salabas E, et al. The relationship between erectile dysfunction and the atherogenic index of plasma. Int J Impot Res. [cited 2019 Jun 26]. DOI:10.1038/s41443-019-0167-2
   Web of Science ®Google Scholar